In recent years, telemedicine has gradually developed in France, particularly in 2020 during the Covid-19 epidemic, when it proved its effectiveness. Favouring access to care for all, it is now part of common medical practices and is covered by the Health Insurance. Considered as a component of medicine by the WHO in its definition of telemedicine, it allows for remote care of patients.
In France, the decree of October 19, 2010 specifies the definition of telemedicine by indicating the procedures that can be performed. Among them are tele-expertise, remote medical monitoring and tele-consultation. These are all different acts, but they all have one thing in common: they are performed at a distance. And as we have seen during BioSerenity’s 5G experimentation, this technology is a real asset to further develop this medical practice.